The results showed that TTCS was superior to NTSC in inducing the migration of tumor‐infiltrating neutrophils, and this effect was almost lost when these neutrophils were pre‐treated with CXCL6/CXCL8 and/or CXCR1 blocking antibodies (Figure 2G). The gene discussed is CXCL8; the disease is neoplasm.